Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 38

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 38
---
.5 | Meeting |

Subject to the terms of this Agreement and the Interim Order, the Company shall:

| (a) | convene and conduct the Meeting in accordance with the Interim Order, the Company’s Constating Documents 
 and Law, as soon as reasonably practicable (and in any event, but subject to availability                |

- 19 -

| of the Court for the Interim Order, on or before the later of: (A) 75 days following the date of this Agreement and (B) 45 days following the SEC Clearance Period (the “Meeting                                                            
 Deadline”)), for the purpose of considering the Arrangement Resolution, the Alternate Resolution and for any other proper purpose as may be set out in the Circular and agreed to by the Purchaser, and not adjourn, postpone or cancel (or 
 propose the adjournment, postponement or cancellation of) the Meeting without the prior written consent of the Purchaser, except:                                                                                                           |

| (i) | in the case of an adjournment, as required for quorum purposes; or |

| (ii) | as required or permitted under Section 6.2(f); |

| (b) | give notice to the Purchaser of the Meeting and allow the Purchaser’s Representatives and outside legal 
 counsel to attend the Meeting;                                                                          |

| (c) | subject to the terms of this Agreement, use commercially reasonable efforts to solicit proxies in favour of the                                                                                                                   
 approval of the Arrangement Resolution and against any resolution submitted by any Shareholder that is inconsistent with the Arrangement Resolution and the completion of any of the transactions contemplated by this Agreement; |

| (d) | provide the Purchaser with copies of or access to information regarding the Meeting generated by the                         
 Company’s transfer agent or any dealer or proxy solicitation services firm, as requested from time to time by the Purchaser; |

| (e) | promptly advise the Purchaser, at such times as the Purchaser may reasonably request and at least on a daily                                                                                                                     
 basis on each of the last 10 Business Days prior to the date of the Meeting, as to the aggregate tally of the proxies (for greater certainty, specifying votes “for” and votes “against” the Arrangement Resolution) received by 
 the Company in respect of the Arrangement Resolution;                                                                                                                                                                            |

| (f) | not change the record date for Shareholders entitled to vote at the Meeting in connection with any adjournment       
 or postponement of the Meeting unless required